Atlas Trials

PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer

Clinical trial NCT03621904 · RECRUITING

Trial details

NCT number
NCT03621904
Sponsor
Radboud University Medical Center
Status
RECRUITING
Study type
OBSERVATIONAL
Endometrial Cancer Stage IIIEndometrial Cancer Stage IVEndometrial Cancer Recurrent
Start date
2022-10-15
Primary completion
2026-10-15
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.